SCHEMBL7701651

SCHEMBL7701651

O=C(Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1)N1CCN(c2ccccn2)CC1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
ALDH1A1 P00352 4/20 0.57
MAPT P10636 3/20 0.56
TRPV1 Q8NER1 1/20 0.53
PANK3 Q9H999 1/20 0.53
NAMPT P43490 7/20 0.53
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA9 Q16790 1/20 0.52
HSD17B10 Q99714 2/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49
CHEK1 O14757 1/20 0.49
KDR P35968 2/20 0.48
CDK1 P06493 1/20 0.48
CDK2 P24941 1/20 0.48
HPGD P15428 1/20 0.46
ROCK2 O75116 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7704717 0.87 KDR (0.55) MAPTNAMPTCA12CA1CA2
SCHEMBL7701118 0.86 KDR (0.61) KDM4ENAMPTCHEK1KDRCDK1
SCHEMBL7701734 0.86 CHEK1 (0.58) NAMPTCHEK1KDRCDK1CDK2
SCHEMBL7704101 0.85 CHEK1 (0.57) ALDH1A1NAMPTCHEK1KDRCDK1
SCHEMBL7002937 0.85 CHEK1 (0.61) NAMPTCA12CA1CA2CA9
SCHEMBL6998816 0.84 GLA (0.55) ALDH1A1MAPTPANK3NAMPTCA12
SCHEMBL7696919 0.82 HTR1A (0.54) MAPTNAMPTCA12CA1CA2
SCHEMBL7094822 0.81 KDR (0.56) KDM4ENAMPTCHEK1KDRCDK1
SCHEMBL7000769 0.78 CHEK1 (0.64) CHEK1KDRCDK1CDK2
SCHEMBL7698438 0.78 LMNA (0.58) ALDH1A1MAPTNAMPTMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed